Clean Energy Technologies Receives Nasdaq Delisting Notice

Clean Energy Technologies Inc. (CETY) received a notice from the Nasdaq Stock Market on or before May 29, 2026, stating that the company fails to satisfy a listing rule, according to an 8-K filed with the SEC that same day.

The filing, submitted under Item 3.01, identifies the specific exchange as Nasdaq and the rule violated but does not publicly detail the exact deficiency in the summary disclosure. As a micro-cap OTC-adjacent issuer with a market presence in clean-energy technology hardware, CETY’s listing status directly affects its roughly 45 million shares outstanding and the liquidity available to its shareholder base.

Prior to the notice the company maintained Nasdaq Capital Market listing, which requires ongoing compliance with minimum bid price, stockholders’ equity, and public float standards. The new state is a formal non-compliance designation that triggers a 180-day cure period under Nasdaq rules.

If CETY regains compliance within that window the matter closes; otherwise the exchange may initiate delisting proceedings, subject to appeal rights.

Downstream, the company must now either execute a reverse split, raise additional equity, or achieve operational results sufficient to meet the violated metric before the cure period expires. A separate 8-K will be required if Nasdaq grants an extension, if the company appeals any delisting determination, or if it regains compliance.

Failure to resolve the issue within regulatory deadlines would force trading onto OTC markets, reducing institutional eligibility, tightening bid-ask spreads, and eliminating the ability to use Form S-3 shelf registration without further SEC review.

This marks the latest instance of a small clean-tech issuer confronting exchange standards after the post-2021 SPAC and direct-listing wave. Nasdaq data show more than 200 companies have received similar deficiency notices in the past 24 months, most tied to sustained sub-$1.00 closing bids or equity thresholds.

The original Nasdaq listing rule package was last substantively updated in 2022 to tighten temporary cure extensions.

Primary sources: SEC Form 8-K filed May 29, 2026 (Accession No. 0001493152-26-026412).